Swan, G E <br/><br/>
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.  [electronic resource] 

 -  The pharmacogenomics journal  2005 
 - 21-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1470-269X 
<br/><br/><label>Standard No.: </label>10.1038/sj.tpj.6500281  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Bupropion--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Humans<br/>Male<br/>Middle Aged<br/>Receptors, Dopamine D2--genetics<br/>Smoking--drug therapy<br/>Smoking Cessation--methods<br/>Treatment Outcome